Announcements on 31 jan provided zero enthusiasm and accordingly the share price is going lower. Raised capital at 5c in June last year, now near 20% lower. Information coming through is same same -nothing groundbreaking in terms income, approvals or effectivenss of the treatments.
Ann: Two key treatment centres treat first patients with OncoSil, page-4
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $13.95K | 2.8M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 23723265 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 6723713 | 9 |
View Market Depth
| Last trade - 10.18am 28/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |